Background The prognosis of hepatocellular carcinoma (HCC) varies considerably among
patients with the same disease stage and characteristics, and only about two thirds show …

Purpose The study aimed to investigate the prognostic role of the preoperative carbohydrate
antigen 19-9 (CA19-9) level in alpha-fetoprotein (AFP)-negative (AFP< 25 ng/ml) …

Serum α-fetoprotein (AFP) is a classical biomarker for both diagnosis and prognosis of
hepatocellular carcinoma (HCC). However, its predictive efficiency for prognosis remains …

Objective The aim of this study was to assess serum levels of presurgical α-fetoprotein (AFP)
and carbohydrate antigen 19-9 (CA19-9) as prognostic markers in patients with hepatic …

Background To investigate the prediction value of preoperative serum alpha-fetoprotein
(AFP) level for the prognosis of hepatocellular carcinoma (HCC), by comparing pathological …

Abstract Background and Aim To study the change in serum alpha fetoprotein (AFP) of
patients with recurrent hepatocellular carcinoma (HCC) after curative resection and to …

Background Assessing the outcomes of surgeries for hepatocellular carcinoma (HCC)
patients who exceed the Milan criteria is necessary. Some studies have demonstrated that …

Background The value of alpha-fetoprotein (AFP) as a prognostic indicator in patients with
hepatocellular carcinoma (HCC) has been proposed in recent studies, but the evidence so …

Background Serum alpha-fetoprotein (AFP) is frequently used to predict posthepatectomy
outcomes in patients with hepatocellular carcinoma (HCC), but its predictive value is still not …

Abstract Background/Aim: Alpha-fetoprotein (AFP) had been used as a prognostic factor in
hepatocellular carcinoma but it was unknown what level of AFP could predict the survival of …